How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,845 results for

Wart Treatment

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Quadrivalent Human Papillomavirus Vaccination: A Promising Treatment for Recalcitrant Cutaneous Warts in Children. (PubMed)

Quadrivalent Human Papillomavirus Vaccination: A Promising Treatment for Recalcitrant Cutaneous Warts in Children. 25824471 2016 08 12 2015 11 04 1651-2057 95 8 2015 Nov Acta dermato-venereologica Acta Derm. Venereol. Quadrivalent human papillomavirus vaccination: a promising treatment for recalcitrant cutaneous warts in children. 1017-9 10.2340/00015555-2111 Abeck Dietrich D Group practice for Dermatology and Allergology, , Munich, Germany. professorabeck@mytum.de. Fölster-Holst Regina R eng (...) Journal Article Sweden Acta Derm Venereol 0370310 0001-5555 0 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 IM Child Female Foot Dermatoses drug therapy Hand Dermatoses drug therapy Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 therapeutic use Humans Male Retreatment Warts drug therapy 2015 4 1 6 0 2015 4 1 6 0 2016 8 16 6 0 ppublish 25824471 10.2340/00015555-2111

Full Text available with Trip Pro

2015 Acta Dermato-Venereologica

162. Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)

Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove (...) one or more studies before adding more. Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02393417 Recruitment Status : Completed First Posted : March 19, 2015 Last Update Posted : April 17, 2018

2015 Clinical Trials

163. Intralesional Mycobacterium w Vaccine Versus Cryotherapy in Treatment of Refractory Extragenital Warts: A Randomized, Open-Label, Comparative Study. (PubMed)

Intralesional Mycobacterium w Vaccine Versus Cryotherapy in Treatment of Refractory Extragenital Warts: A Randomized, Open-Label, Comparative Study. Initial reports of immunotherapy using intralesional Mycobacterium w (Mw) vaccine have documented its useful role in treatment of genital and extragenital warts.To compare the efficacy and safety of intralesional Mw vaccine versus cryotherapy in the treatment of refractory extragenital warts.This was a prospective, randomized, comparative study (...) of 66 patients. The outcome was assessed in terms of complete clearance of warts and change in Dermatology Life Quality Index (DLQI) score.Complete clearance of treated warts was seen in 66.7% (20/30) and 65.5% (19/29) of patients in the Mw and cryotherapy groups, respectively (P = .769). Clearance of distant warts was significantly (P = .004) high in the Mw group. Improvement in DLQI was greater in the Mw group. Both treatment modalities were well tolerated, and no major side effects occurred.Mw

2015 Journal of cutaneous medicine and surgery Controlled trial quality: uncertain

164. Topical adapalene in the treatment of plantar warts; randomized comparative open trial in comparison with cryo-therapy. (PubMed)

Topical adapalene in the treatment of plantar warts; randomized comparative open trial in comparison with cryo-therapy. Various therapeutic modalities, which are available for treating plantar wart, have not been successful every time.To evaluate topical adapalene under occlusion in the treatment of plantar warts and compare it with cryo-therapy.50 patients with 424 plantar warts were included in this single center, two arm, prospective, randomized, control, open study. Patients were allocated (...) except one treated by cryo-therapy cleared in 52.17 ± 30.06 (82.23-22.11) days. There were no side effects like scar formation, irritation, erythema, or infections with adapalene group while in the cryo group scar was seen in 2 patients, pain in 24, erythema in 10, and infection in 3 patients.Adapalene gel 0.1% under occlusion is an effective, safe and easy to use treatment for plantar warts and may help clear lesions faster than cryo-therapy.

Full Text available with Trip Pro

2015 Indian journal of dermatology Controlled trial quality: uncertain

165. A single-blinded randomized controlled study to assess the efficacy of twice daily application of sinecatechins 15% ointment when used sequentially with cryotherapy in the treatment of external genital warts. (PubMed)

A single-blinded randomized controlled study to assess the efficacy of twice daily application of sinecatechins 15% ointment when used sequentially with cryotherapy in the treatment of external genital warts. To evaluate the efficacy of sequential therapy of cryotherapy and sinecatechins 15% ointment BID versus cryotherapy alone in treatment of external genital warts (EGW).Forty-two subjects with at least two EGW lesions underwent cryotherapy to all lesions. One week following cryotherapy (...) , subjects were randomized 1:1 to receive either no additional treatment or treatment with sinecatechins 15% ointment BID up to 16 weeks or until complete clearance. The total number of visible baseline and new EGW were recorded at each visit. Subjects were followed for a total of 65 weeks post-treatment.There was a significant reduction in mean number of lesions from baseline after 16 weeks of treatment in the cryotherapy-sinecatechins ointment group compared to cryotherapy alone (-5.0 lesions vs -2.1

2015 Journal of drugs in dermatology : JDD Controlled trial quality: uncertain

166. Topical pyruvic acid (70%) versus topical salicylic acid (16.7%) compound in treatment of plantar warts: A randomized controlled trial. (PubMed)

Topical pyruvic acid (70%) versus topical salicylic acid (16.7%) compound in treatment of plantar warts: A randomized controlled trial. Recurrence rate is considerable with current topical treatments of plantar warts. We compared the efficacy of topical pyruvic acid (70%) with salicylic acid (16.7%) compound in treating multiple plantar warts.In this randomized controlled trial, 60 patients with multiple plantar warts were equally randomized to receive either pyruvic acid 70% or compound (...) salicylic acid solution (salicylic acid 16.7%, lactic acid 16.7%, and collodion 100%) that was topically applied twice a day for 4 weeks. Patients were visited every 2 weeks for 1 month after starting treatment and then every 1 month for another 2 months. The number and size of warts, treatment complications (pain, burning, scar, pigmentation, and crust), and recurrence were evaluated.Warts' number was decreased by -13.12 ± 25.6% with pyruvic acid and by -23.0 ± 28.0% with compound salicylic acid (P

Full Text available with Trip Pro

2015 Advanced biomedical research Controlled trial quality: uncertain

167. A Novel Topical 2% Povidone-Iodine Solution for the Treatment of Common Warts: A Randomized, Double-Blind, Vehicle-Controlled Trial. (PubMed)

A Novel Topical 2% Povidone-Iodine Solution for the Treatment of Common Warts: A Randomized, Double-Blind, Vehicle-Controlled Trial. Verruca vulgaris, also known as common warts, are benign skin growths caused by infection of the skin by human papillomavirus. Warts are common in both childhood and adulthood and are spread by direct contact or autoinoculation. Treatment options vary from locally destructive methods to immuno-modulatory therapy. Common warts are often resistant to treatment (...) . Sustained improvement in the GAIS scale was observed at the final week 12 exam visit in 77% of subjects in the treatment arm and 33% of patients in the control arm. There were no serious safety or tolerability issues reported.Twice-daily topical povidone-iodine solution in the novel vehicle employed for this study is an effective, safe and easy-to-use treatment for common warts. Further study of this agent in expanded Phase II and Phase III clinical trials is warranted.ALC Therapeutics LLC.

Full Text available with Trip Pro

2015 Dermatology and therapy Controlled trial quality: uncertain

168. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study. (PubMed)

Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study. Intralesional purified protein derivative (PPD) or mumps, measles, rubella (MMR) were not previously compared regarding their efficacy or mechanism of action in treatment of warts. We aimed to compare their efficacy in treatment of multiple warts and investigate their effect on serum interleukin (IL)-4 and IL-12. Thirty patients (...) with multiple warts were included (10 treated with PPD, 10 with MMR, and 10 with normal saline (control)). Injection was done every 3 weeks until clearance or maximum of three treatments. Clinical response of target and distant warts was evaluated. Serum ILs-4 and -12 were assessed before and after treatment. A significantly higher rate of complete response was found in target and distant warts with PPD (60% each) and MMR (80%, 40%, respectively) compared with controls (0%), with no significant difference

2015 Dermatologic therapy Controlled trial quality: uncertain

169. Interferon for the treatment of genital warts: a systematic review

Interferon for the treatment of genital warts: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

170. High prevalence of cutaneous warts in elementary school children and ubiquitous presence of wart-associated HPV on clinically normal skin. (PubMed)

High prevalence of cutaneous warts in elementary school children and ubiquitous presence of wart-associated HPV on clinically normal skin. One-third of Dutch primary school children have cutaneous warts; each year around 20% of them seek medical treatment. However, little is known about the epidemiology of the types of human papillomavirus (HPV) causing these warts.To investigate the distribution of cutaneous wart-associated HPV types in three primary school classes by analysing skin swabs (...) taken from warts, and the forehead, hand dorsum and sole of the foot of included children.Using the hyperkeratotic skin lesion polymerase chain reaction/multiplex genotyping assay, each swab sample was used to genotype for 23 cutaneous wart-associated HPV types.Thirty-one (44%) of the 71 children had a total of 69 warts, with a maximum of six warts per child. In the wart swabs, HPV2, HPV27 and HPV57, members of Alphapapillomavirus species 4, were most frequently detected (27%, 32% and 14

2014 British Journal of Dermatology

171. Imiquimod in the treatment of cutaneous warts: an evidence-based review. (PubMed)

Imiquimod in the treatment of cutaneous warts: an evidence-based review. Cutaneous warts are highly prevalent lesions caused by the infection of keratinocytes by different types of human papillomaviruses. Although cutaneous warts are capable of resolving spontaneously, these infections can persist for long periods of time by evading the host immune system, and, as a result, many patients choose to seek treatment. Imiquimod is an immune response modifier that is approved as a topical cream (...) for the treatment of anogenital warts by the US Food and Drug Administration. However, the efficacy of imiquimod in the treatment of cutaneous warts has not been well established.The purpose of this article is to systematically review the published literature regarding the efficacy of imiquimod in the treatment of cutaneous warts, and to evaluate the quality and outcomes of these studies.A literature search was performed through clinical queries PubMed (National Library of Medicine) database and the Cochrane

2014 American journal of clinical dermatology

172. Pulsed dye laser treatment for recalcitrant viral warts: a retrospective case series of 227 patients. (PubMed)

Pulsed dye laser treatment for recalcitrant viral warts: a retrospective case series of 227 patients. 24813813 2015 07 14 2014 11 21 1365-2133 171 5 2014 Nov The British journal of dermatology Br. J. Dermatol. Pulsed-dye laser treatment for recalcitrant viral warts: a retrospective case series of 227 patients. 1270-3 10.1111/bjd.13099 Sparreboom E E EE Department of Dermatology, Máxima Medical Centre Veldhoven, De Run 4600, P.O. Box 7777, 5500 MB, Veldhoven, the Netherlands. Luijks H G HG (...) Luiting-Welkenhuyzen H A L HA Willems P W J M PW Groeneveld C P M CP Bovenschen H J HJ eng Letter 2014 09 26 England Br J Dermatol 0004041 0007-0963 IM Adolescent Adult Aged Child Child, Preschool Cicatrix etiology Female Humans Infant Infant, Newborn Lasers, Dye therapeutic use Male Middle Aged Prospective Studies Retrospective Studies Treatment Outcome Warts surgery Young Adult 2014 5 13 6 0 2014 5 13 6 0 2015 7 15 6 0 ppublish 24813813 10.1111/bjd.13099

2014 British Journal of Dermatology

173. Investigations of the efficacy of diphenylcyclopropenone immunotherapy for the treatment of warts. (PubMed)

Investigations of the efficacy of diphenylcyclopropenone immunotherapy for the treatment of warts. Diphenylcyclopropenone (DPCP) immunotherapy has been used to treat warts, particularly in patients, such as children, who cannot endure treatment-related pain and in patients with large numbers of warts. However, the efficacy of DPCP immunotherapy remains subject to much controversy. Specifically, cure rates and treatment durations have varied across reports, primarily because of the lack of large (...) -scale studies.We performed an uncontrolled, open-label study to investigate the efficacy of DPCP immunotherapy for the treatment of cutaneous warts. A total of 170 patients with warts were enrolled in this uncontrolled, open-label study from 2006 to 2012. Each patient was sensitized with 0.1% DPCP. Two weeks after sensitization, DPCP was applied to warts once per week.We achieved high clearance rates in 141 of 170 patients (82.9%) and 434 of 511 lesions (84.9%). Immunotherapy with DPCP was much more

2014 International Journal of Dermatology

174. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach. (PubMed)

Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach. Recalcitrant warts represent a frustrating challenge for both patients and physicians. Although many destructive and immunotherapeutic modalities are available for the treatment of warts, an ideal, universally effective approach has not been explored to date. Recently, intralesional antigen immunotherapy has shown promising efficacy in the treatment of warts. The aim of the study (...) was to evaluate the efficacy and safety of intralesional measles, mumps, and rubella (MMR) vaccine in the treatment of recalcitrant warts.The study included 70 adult patients with multiple recalcitrant extragenital warts of different sizes and durations, with or without distant warts. They were directly injected, without a pre-sensitization skin test, with 0.3 intralesional MMR vaccine into the largest wart at 2-week intervals until complete clearance or for a maximum of five treatments. Follow-up was made

2014 International Journal of Dermatology

175. Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts

Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02151630 Recruitment Status : Unknown Verified May 2014 by Fatima Assaf, Isfahan University of Medical Sciences. Recruitment status was: Recruiting First Posted : May 30, 2014

2014 Clinical Trials

176. Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment

Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02147353 Recruitment Status : Completed First Posted : May 26, 2014 Last Update Posted : July 10, 2015 Sponsor: Icahn School of Medicine at Mount Sinai

2014 Clinical Trials

177. Subcutaneous intralesional Ksharodaka injection: A novel treatment for the management of Warts: A case series (PubMed)

Subcutaneous intralesional Ksharodaka injection: A novel treatment for the management of Warts: A case series Warts are generally managed using cryosurgery, keratolytic ointments, curettage and electrodessication. Warts, vis-a-vis Charmakila, in Ayurvedic classical texts are classified into different types depending on the dominance of dosha. Ayurveda prescribes oral medications, topical use of Kshara (alkaline ash of herbs), Agni (thermal cautery) and Shastrakarma (surgery) for removal (...) of Charmakila. Use of topical Kshara in the form of powder, aqueous solution i.e. Ksharodaka and Ksharasutra (thread smeared with Kshara) for warts has been reported. However, these methods necessitate multiple sittings and takea longer duration for removal of the warts. Herewith, we report a case series of different types of warts treated with intralesional infiltration of Apamarga Ksharodaka (AK), i.e. aqueous solution of Apamarga (Achyranthes aspera) Kshara. We observed that all these warts took

Full Text available with Trip Pro

2014 Journal of Ayurveda and integrative medicine

178. Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta-analysis.

Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta-analysis. External anogenital warts (EGWs) are non-malignant skin tumours caused by human papillomavirus. They are one of the fastest growing sexually transmitted diseases. Current treatments are unsatisfactory. Green tea sinecatechin Polyphenon E ointment is a botanical extract from green tea leaves exhibiting anti-oxidant, anti-viral and anti-tumour (...) evaluating efficacy and safety of Polyphenon E 15% and 10% in the treatment of warts were included in the systematic review and meta-analysis. A total of 660 men and 587 women were enrolled. Regarding primary outcome, both Polyphenon E 15% and 10% demonstrated significantly higher likelihood of complete clearance of baseline and baseline and new warts compared with controls. No significant heterogeneity was detected. Recurrence rates were very low. Commonest local skin sign was erythema and local skin

2014 Journal of the European Academy of Dermatology and Venereology : JEADV

179. Comparison of efficacy of 5% potassium hydroxide solution versus cryotherapy in the treatment of male genital wart: a randomized clinical trial. (PubMed)

Comparison of efficacy of 5% potassium hydroxide solution versus cryotherapy in the treatment of male genital wart: a randomized clinical trial. 24566576 2014 06 02 2014 09 26 0392-0488 149 1 2014 Feb Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia G Ital Dermatol Venereol Comparison of efficacy of 5% potassium hydroxide solution versus cryotherapy in the treatment of male genital wart: a randomized clinical trial. 149-50

2014 Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia Controlled trial quality: uncertain

180. Efficacy of Myrtus communis L. and Descurainia sophia L. Versus Salicylic Acid for Wart Treatment (PubMed)

Efficacy of Myrtus communis L. and Descurainia sophia L. Versus Salicylic Acid for Wart Treatment Wart is a skin disease with circular appendages, which is called "suloul" in Iranian traditional medicine (ITM). According to ITM literature, warts have different types and causes. The most important mechanism is excretion of materials (Khelt) from body to skin and mucus; its causative material is often phlegm, black bile or a combination of them. To treat warts, it is necessary to consider (...) groups (P < 0.001). Relapse was not seen in any groups after three months. The frequency of side effects was similar after three months.M. communis L. can be used as a topical treatment for warts. It not only shows more rapid response than salicylic acid, but also has fewer side effects. It seems that D. sophia L. can modify the digestion process and patients can excrete large amounts of the substance that causes warts. Therefore, it is better to use it more than 40 days. According to our

Full Text available with Trip Pro

2014 Iranian Red Crescent medical journal Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>